{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T20:54:40Z","timestamp":1787691280601,"version":"build-2784847793"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,25]],"date-time":"2021-11-25T00:00:00Z","timestamp":1637798400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003554","name":"Lundbeckfonden","doi-asserted-by":"publisher","award":["R290-2018-751"],"award-info":[{"award-number":["R290-2018-751"]}],"id":[{"id":"10.13039\/501100003554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology Practice"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1016\/j.cnp.2021.11.001","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T12:29:51Z","timestamp":1638361791000},"page":"1-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["A test to determine the site of abnormal neuromuscular refractoriness"],"prefix":"10.1016","volume":"7","author":[{"given":"Hatice","family":"Tankisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Bostock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Grafe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.cnp.2021.11.001_b0005","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/mus.26852","article-title":"Cold aggravates abnormal excitability of motor axons in oxaliplatin-treated patients","volume":"61","author":"Bennedsgaard","year":"2020","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.cnp.2021.11.001_b0010","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.neucli.2004.08.002","article-title":"Methods and clinical value of peripheral nerve refractory period measurement in man","volume":"34","author":"Bo\u00ebrio","year":"2004","journal-title":"Neurophysiol. Clin."},{"issue":"4","key":"10.1016\/j.cnp.2021.11.001_b0015","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.clinph.2004.11.018","article-title":"A reappraisal of various methods for measuring motor nerve refractory period in humans","volume":"116","author":"Bo\u00ebrio","year":"2005","journal-title":"Clin. Neurophysiol."},{"issue":"11","key":"10.1016\/j.cnp.2021.11.001_b0020","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.clinph.2007.07.018","article-title":"Neuromuscular excitability properties in myotonic dystrophy type 1","volume":"118","author":"Bo\u00ebrio","year":"2007","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.cnp.2021.11.001_b0025","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1529-8027.2010.00275.x","article-title":"Is cold paresis related to axonal depolarization?","volume":"15","author":"Franssen","year":"2010","journal-title":"J. Peripher. Nerv. Syst."},{"issue":"3","key":"10.1016\/j.cnp.2021.11.001_b0030","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.clinph.2017.11.015","article-title":"Axonal excitability changes and acute symptoms of oxaliplatin treatment: In vivo evidence for slowed sodium channel inactivation","volume":"129","author":"Heide","year":"2018","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.cnp.2021.11.001_b0035","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1093\/brain\/123.12.2542","article-title":"Effects of membrane polarization and ischaemia on the excitability properties of human motor axons","volume":"123","author":"Kiernan","year":"2000","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.cnp.2021.11.001_b0040","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.clinph.2019.07.023","article-title":"Measurement of axonal excitability: Consensus guidelines","volume":"131","author":"Kiernan","year":"2020","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.cnp.2021.11.001_b0045","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/brain\/124.4.816","article-title":"Effects of temperature on the excitability properties of human motor axons","volume":"124","author":"Kiernan","year":"2001","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.cnp.2021.11.001_b0050","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/j.clinph.2020.08.004","article-title":"Excitability of motor and sensory axons in multifocal motor neuropathy","volume":"131","author":"Kovalchuk","year":"2020","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.cnp.2021.11.001_b0055","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1093\/brain\/awh558","article-title":"Altered motor nerve excitability in end-stage kidney disease","volume":"128","author":"Krishnan","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.cnp.2021.11.001_b0060","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/mus.10488","article-title":"The refractory period of transmission is impaired in axonal Guillain-Barre syndrome","volume":"28","author":"Kuwabara","year":"2003","journal-title":"Muscle Nerve"},{"issue":"11","key":"10.1016\/j.cnp.2021.11.001_b0065","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.clinph.2020.07.025","article-title":"Neuropathy in sporadic inclusion body myositis: A multi-modality neurophysiological study","volume":"131","author":"Lee","year":"2020","journal-title":"Clin Neurophysiol"},{"issue":"4","key":"10.1016\/j.cnp.2021.11.001_b0070","doi-asserted-by":"crossref","first-page":"e18469","DOI":"10.1371\/journal.pone.0018469","article-title":"Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity","volume":"6","author":"Park","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.cnp.2021.11.001_b0075","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.clinph.2019.05.008","article-title":"Standards for quantification of EMG and neurography","volume":"130","author":"St\u00e5lberg","year":"2019","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.cnp.2021.11.001_b0080","doi-asserted-by":"crossref","first-page":"3530","DOI":"10.1093\/brain\/awq318","article-title":"Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1","volume":"133","author":"Tomlinson","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.cnp.2021.11.001_b0085","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/brain\/awl191","article-title":"Nerve excitability changes in critical illness polyneuropathy","volume":"129","author":"Z'Graggen","year":"2006","journal-title":"Brain"}],"container-title":["Clinical Neurophysiology Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2467981X21000470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2467981X21000470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T02:07:25Z","timestamp":1762826845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2467981X21000470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":17,"alternative-id":["S2467981X21000470"],"URL":"https:\/\/doi.org\/10.1016\/j.cnp.2021.11.001","relation":{},"ISSN":["2467-981X"],"issn-type":[{"value":"2467-981X","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A test to determine the site of abnormal neuromuscular refractoriness","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cnp.2021.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Federation of Clinical Neurophysiology. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}